(NEXA) Nexa Resources - Overview
Exchange: NYSE •
Country: Luxembourg •
Currency: USD •
Type: Common Stock •
ISIN: LU1701428291
Stock: Zinc, Metals, Chemicals, Byproducts
Total Rating 69
Risk 50
Buy Signal 0.41
| Risk 5d forecast | |
|---|---|
| Volatility | 92.1% |
| Relative Tail Risk | -7.20% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.78 |
| Alpha | 112.60 |
| Character TTM | |
|---|---|
| Beta | 0.618 |
| Beta Downside | 0.886 |
| Drawdowns 3y | |
|---|---|
| Max DD | 47.02% |
| CAGR/Max DD | 0.62 |
EPS (Earnings per Share)
Revenue
Description: NEXA Nexa Resources March 05, 2026
Nexa Resources SA (NEXA) operates in the zinc mining and smelting sectors globally. The companys business model includes both extraction (mining) and processing (smelting) of zinc and various by-products.
The company produces metallic zinc, zamac, and zinc oxide. By-products include copper, lead, silver, gold, and sulfuric acid. This diversified output is common in polymetallic mining operations.
NEXA owns four polymetallic mines: two in Peru and two in Brazil. It also operates three zinc smelters: one in Peru and two in Brazil. These smelters recover and produce metallic zinc, zinc oxide, and other by-products.
Nexa Resources SA was founded in 1956 and is headquartered in Luxembourg. It is a subsidiary of Votorantim S.A. To explore further financial details and historical data, ValueRay offers comprehensive company profiles.
Headlines to watch out for
- Global zinc prices significantly impact mining and smelting revenue
- Production costs influenced by energy and labor expenses
- Regulatory changes in Peru and Brazil affect mining operations
- By-product sales from copper, lead, and silver boost profitability
- Economic conditions in South America drive demand for metals
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 132.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -1.41 > 1.0 |
| NWC/Revenue: -6.54% < 20% (prev 2.24%; Δ -8.78% < -1%) |
| CFO/TA 0.08 > 3% & CFO 415.9m > Net Income 132.6m |
| Net Debt (1.31b) to EBITDA (939.0m): 1.40 < 3 |
| Current Ratio: 0.87 > 1.5 & < 3 |
| Outstanding Shares: last quarter (132.4m) vs 12m ago 0.00% < -2% |
| Gross Margin: 19.72% > 18% (prev 0.17%; Δ 1.95k % > 0.5%) |
| Asset Turnover: 60.19% > 50% (prev 59.71%; Δ 0.48% > 0%) |
| Interest Coverage Ratio: 2.20 > 6 (EBITDA TTM 939.0m / Interest Expense TTM 273.8m) |
Altman Z'' -0.44
| A: -0.04 (Total Current Assets 1.27b - Total Current Liabilities 1.47b) / Total Assets 5.27b |
| B: -0.21 (Retained Earnings -1.11b / Total Assets 5.27b) |
| C: 0.12 (EBIT TTM 603.4m / Avg Total Assets 4.96b) |
| D: -0.31 (Book Value of Equity -1.24b / Total Liabilities 3.99b) |
| Altman-Z'' Score: -0.44 = B |
Beneish M -2.70
| DSRI: 1.50 (Receivables 240.4m/148.4m, Revenue 2.98b/2.77b) |
| GMI: 0.88 (GM 19.72% / 17.44%) |
| AQI: 1.03 (AQ_t 0.28 / AQ_t-1 0.27) |
| SGI: 1.08 (Revenue 2.98b / 2.77b) |
| TATA: -0.05 (NI 132.6m - CFO 415.9m) / TA 5.27b) |
| Beneish M-Score: -2.70 (Cap -4..+1) = A |
What is the price of NEXA shares?
As of March 13, 2026, the stock is trading at USD 11.67 with a total of 602,809 shares traded.
Over the past week, the price has changed by -6.57%, over one month by -5.74%, over three months by +42.49% and over the past year by +130.45%.
Over the past week, the price has changed by -6.57%, over one month by -5.74%, over three months by +42.49% and over the past year by +130.45%.
Is NEXA a buy, sell or hold?
Nexa Resources has received a consensus analysts rating of 2.75.
Therefor, it is recommend to hold NEXA.
- StrongBuy: 0
- Buy: 0
- Hold: 6
- Sell: 2
- StrongSell: 0
What are the forecasts/targets for the NEXA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 10.3 | -11.4% |
| Analysts Target Price | 10.3 | -11.4% |
NEXA Fundamental Data Overview March 09, 2026
P/E Trailing = 10.87
P/E Forward = 3.4495
P/S = 0.4795
P/B = 1.4354
Revenue TTM = 2.98b USD
EBIT TTM = 603.4m USD
EBITDA TTM = 939.0m USD
Long Term Debt = 1.72b USD (from longTermDebt, two quarters ago)
Short Term Debt = 100.9m USD (from shortTermDebt, last quarter)
Debt = 1.83b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.31b USD (from netDebt column, last quarter)
Enterprise Value = 2.75b USD (1.44b + Debt 1.83b - CCE 521.6m)
Interest Coverage Ratio = 2.20 (Ebit TTM 603.4m / Interest Expense TTM 273.8m)
EV/FCF = 61.13x (Enterprise Value 2.75b / FCF TTM 44.9m)
FCF Yield = 1.64% (FCF TTM 44.9m / Enterprise Value 2.75b)
FCF Margin = 1.51% (FCF TTM 44.9m / Revenue TTM 2.98b)
Net Margin = 4.45% (Net Income TTM 132.6m / Revenue TTM 2.98b)
Gross Margin = 19.72% ((Revenue TTM 2.98b - Cost of Revenue TTM 2.39b) / Revenue TTM)
Gross Margin QoQ = 22.81% (prev 16.59%)
Tobins Q-Ratio = 0.52 (Enterprise Value 2.75b / Total Assets 5.27b)
Interest Expense / Debt = 4.81% (Interest Expense 87.8m / Debt 1.83b)
Taxrate = 18.10% (17.9m / 98.9m)
NOPAT = 494.2m (EBIT 603.4m * (1 - 18.10%))
Current Ratio = 0.87 (Total Current Assets 1.27b / Total Current Liabilities 1.47b)
Debt / Equity = 1.82 (Debt 1.83b / totalStockholderEquity, last quarter 1.00b)
Debt / EBITDA = 1.40 (Net Debt 1.31b / EBITDA 939.0m)
Debt / FCF = 29.20 (Net Debt 1.31b / FCF TTM 44.9m)
Total Stockholder Equity = 934.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.68% (Net Income 132.6m / Total Assets 5.27b)
RoE = 14.19% (Net Income TTM 132.6m / Total Stockholder Equity 934.8m)
RoCE = 22.70% (EBIT 603.4m / Capital Employed (Equity 934.8m + L.T.Debt 1.72b))
RoIC = 18.33% (NOPAT 494.2m / Invested Capital 2.70b)
WACC = 5.81% (E(1.44b)/V(3.27b) * Re(8.18%) + D(1.83b)/V(3.27b) * Rd(4.81%) * (1-Tc(0.18)))
Discount Rate = 8.18% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.00%
[DCF] Terminal Value 80.82% ; FCFF base≈68.9m ; Y1≈45.2m ; Y5≈20.6m
[DCF] Fair Price = N/A (negative equity: EV 657.2m - Net Debt 1.31b = -654.0m; debt exceeds intrinsic value)
EPS Correlation: 14.41 | EPS CAGR: 6.13% | SUE: 0.24 | # QB: 0
Revenue Correlation: 10.58 | Revenue CAGR: 5.92% | SUE: 3.58 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.49 | Chg7d=-0.140 | Chg30d=+0.490 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-12-31): EPS=1.89 | Chg7d=+0.110 | Chg30d=+0.170 | Revisions Net=+1 | Growth EPS=+122.0% | Growth Revenue=+3.5%
EPS next Year (2027-12-31): EPS=1.71 | Chg7d=+0.000 | Chg30d=-0.030 | Revisions Net=+1 | Growth EPS=-9.4% | Growth Revenue=-1.3%
[Analyst] Revisions Ratio: +0.33 (2 Up / 1 Down within 30d for Current Year)
[Growth] Implied Growth Rate = -1.0% (Discount Rate 8.2% - Earnings Yield 9.2%)
[Growth] Growth Spread = +30.8% (Analyst 29.8% - Implied -1.0%)
P/E Forward = 3.4495
P/S = 0.4795
P/B = 1.4354
Revenue TTM = 2.98b USD
EBIT TTM = 603.4m USD
EBITDA TTM = 939.0m USD
Long Term Debt = 1.72b USD (from longTermDebt, two quarters ago)
Short Term Debt = 100.9m USD (from shortTermDebt, last quarter)
Debt = 1.83b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.31b USD (from netDebt column, last quarter)
Enterprise Value = 2.75b USD (1.44b + Debt 1.83b - CCE 521.6m)
Interest Coverage Ratio = 2.20 (Ebit TTM 603.4m / Interest Expense TTM 273.8m)
EV/FCF = 61.13x (Enterprise Value 2.75b / FCF TTM 44.9m)
FCF Yield = 1.64% (FCF TTM 44.9m / Enterprise Value 2.75b)
FCF Margin = 1.51% (FCF TTM 44.9m / Revenue TTM 2.98b)
Net Margin = 4.45% (Net Income TTM 132.6m / Revenue TTM 2.98b)
Gross Margin = 19.72% ((Revenue TTM 2.98b - Cost of Revenue TTM 2.39b) / Revenue TTM)
Gross Margin QoQ = 22.81% (prev 16.59%)
Tobins Q-Ratio = 0.52 (Enterprise Value 2.75b / Total Assets 5.27b)
Interest Expense / Debt = 4.81% (Interest Expense 87.8m / Debt 1.83b)
Taxrate = 18.10% (17.9m / 98.9m)
NOPAT = 494.2m (EBIT 603.4m * (1 - 18.10%))
Current Ratio = 0.87 (Total Current Assets 1.27b / Total Current Liabilities 1.47b)
Debt / Equity = 1.82 (Debt 1.83b / totalStockholderEquity, last quarter 1.00b)
Debt / EBITDA = 1.40 (Net Debt 1.31b / EBITDA 939.0m)
Debt / FCF = 29.20 (Net Debt 1.31b / FCF TTM 44.9m)
Total Stockholder Equity = 934.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.68% (Net Income 132.6m / Total Assets 5.27b)
RoE = 14.19% (Net Income TTM 132.6m / Total Stockholder Equity 934.8m)
RoCE = 22.70% (EBIT 603.4m / Capital Employed (Equity 934.8m + L.T.Debt 1.72b))
RoIC = 18.33% (NOPAT 494.2m / Invested Capital 2.70b)
WACC = 5.81% (E(1.44b)/V(3.27b) * Re(8.18%) + D(1.83b)/V(3.27b) * Rd(4.81%) * (1-Tc(0.18)))
Discount Rate = 8.18% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.00%
[DCF] Terminal Value 80.82% ; FCFF base≈68.9m ; Y1≈45.2m ; Y5≈20.6m
[DCF] Fair Price = N/A (negative equity: EV 657.2m - Net Debt 1.31b = -654.0m; debt exceeds intrinsic value)
EPS Correlation: 14.41 | EPS CAGR: 6.13% | SUE: 0.24 | # QB: 0
Revenue Correlation: 10.58 | Revenue CAGR: 5.92% | SUE: 3.58 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.49 | Chg7d=-0.140 | Chg30d=+0.490 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-12-31): EPS=1.89 | Chg7d=+0.110 | Chg30d=+0.170 | Revisions Net=+1 | Growth EPS=+122.0% | Growth Revenue=+3.5%
EPS next Year (2027-12-31): EPS=1.71 | Chg7d=+0.000 | Chg30d=-0.030 | Revisions Net=+1 | Growth EPS=-9.4% | Growth Revenue=-1.3%
[Analyst] Revisions Ratio: +0.33 (2 Up / 1 Down within 30d for Current Year)
[Growth] Implied Growth Rate = -1.0% (Discount Rate 8.2% - Earnings Yield 9.2%)
[Growth] Growth Spread = +30.8% (Analyst 29.8% - Implied -1.0%)